Trial intelligence / Profile preview

Tianshu Capsule for migraine prevention and gut microbiota modulation

ChiCTR1800019629Phase 4Recruiting

Sponsor
Chinese PLA General Hospital
Start
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of Tianshu in migraine (3 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Frequency of headache, Duration of headache and 2 more. Started Dec 2017; status: recruiting.

02

Drugs

Tianshu
03

Conditions

migraine

Beyond the preview

Go deeper on ChiCTR1800019629.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800019629.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call